연구성과로 돌아가기

2025 연구자 정보 (485 / 657)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 교신저자 여부 Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Lee, Won Sik
(Lee, WS)
Inje Univ, Busan Paik Hosp, Dept Internal Med, Hematol, Busan, South Korea
Inje Univ, Dept Internal Med, Hematol, Busan Paik Hosp, Busan, South Korea


[JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions
[JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions (vol 60, 9, 2025)
ESCI 36.2 HEMATOLOGY kihyunkimk@gmail.com;
Lim, Jihyang
(Lim, J)
Catholic Univ Korea, Dept Lab Med, Eunpyeong St Marys Hosp, Coll Med, Seoul, South Korea

[JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions
[JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions (vol 60, 9, 2025)
ESCI 36.2 HEMATOLOGY kihyunkimk@gmail.com;
Lim, Sung-Nam
(Lim, SN)
Inje Univ, Coll Med, Haeundae Paik Hosp, Dept Internal Med, Busan, South Korea

[JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions
[JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions (vol 60, 9, 2025)
ESCI 36.2 HEMATOLOGY kihyunkimk@gmail.com;
Min, Chang-Ki
(Min, CK)
Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Seoul, South Korea

[JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions
[JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions (vol 60, 9, 2025)
ESCI 36.2 HEMATOLOGY kihyunkimk@gmail.com;
Mun, Yeung-Chul
(Mun, YC)
Ewha Womans Univ, Coll Med, Dept Internal Med, Seoul, South Korea

[JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions
[JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions (vol 60, 9, 2025)
ESCI 36.2 HEMATOLOGY kihyunkimk@gmail.com;
Park, Sung-Soo
(Park, SS)
Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Seoul, South Korea

[JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions
[JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions (vol 60, 9, 2025)
ESCI 36.2 HEMATOLOGY kihyunkimk@gmail.com;
Yhim, Ho-Young
(Yhim, HY)
Jeonbuk Natl Univ, Med Sch, Dept Internal Med, Jeonju, South Korea

[JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions
[JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions (vol 60, 9, 2025)
ESCI 36.2 HEMATOLOGY kihyunkimk@gmail.com;
Yi, Jun Ho
(Yi, JH)
Chung Ang Univ, Dept Med, Div Hematol Oncol, Seoul, South Korea GXZ-8144-2022
Yi, Jun Ho

[JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions
[JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions (vol 60, 9, 2025)
ESCI 36.2 HEMATOLOGY kihyunkimk@gmail.com;
Yoon, Dok Hyun
(Yoon, DH)
Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea

[JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions
[JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions (vol 60, 9, 2025)
ESCI 36.2 HEMATOLOGY kihyunkimk@gmail.com;
Yoon, Sang Eun
(Yoon, SE)
Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Div Hematol Oncol,Dept Med, 81 Irwon Ro, Seoul, South Korea

[JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions
[JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions (vol 60, 9, 2025)
ESCI 36.2 HEMATOLOGY kihyunkimk@gmail.com;
Ahn, Sung-Hoon
(Ahn, SH)
교신저자 Seoul Natl Univ, Dept Mech Engn, Seoul, South Korea
Seoul Natl Univ, Inst Adv Machines & Design, Seoul, South Korea


[JCR상위 36.5] Data-driven analysis of bonding strength in laser-structured metal-GFRP hybrid joints via groove morphology SCIE 36.5 AUTOMATION & CONTROL SYSTEMS;ENGINEERING, MANUFACTURING ahnsh@snu.ac.kr;
Ahn, Young-Ho
(Ahn, YH)
교신저자 Yeungnam Univ, Dept Civil Engn, Environm Sci & Engn Lab, Geongsan 38541, South Korea

[JCR상위 36.5] The influence of operational factors on the photocatalytic degradation of methylene blue dye in aqueous Sr-Au-ZnO suspensions under UV-A light SCIE 36.5 CHEMISTRY, PHYSICAL chemsel@yahoo.com; kbalu@us.es; yhahn@ynu.ac.kr; shanthimsm@gmail.com;
Ali, Umair
(Ali, U)
Kyungpook Natl Univ, Dept Chem, Daegu 41566, South Korea

[JCR상위 36.5] Investigating the efficacy of Palladium Doped Ceria for the Photodegradation of Azo Dyes SCIE 36.5 CHEMISTRY, PHYSICAL yaoyt99@163.com;
Balu, Krishnakumar
(Balu, K)
교신저자 Saveetha Inst Med & Tech Sci SIMATS, Saveetha Sch Engn, Chennai 602105, Tamil Nadu, India H-9038-2019
Balu, Krishnakumar
0000-0003-0957-4978
Balu, Krishnakumar
[JCR상위 36.5] The influence of operational factors on the photocatalytic degradation of methylene blue dye in aqueous Sr-Au-ZnO suspensions under UV-A light SCIE 36.5 CHEMISTRY, PHYSICAL chemsel@yahoo.com; kbalu@us.es; yhahn@ynu.ac.kr; shanthimsm@gmail.com;
Choi, Jun Young
(Choi, JY)
제1저자 Seoul Natl Univ, Dept Mech Engn, Seoul, South Korea
ABION Inc, R&D Ctr, Seoul, South Korea
AAY-2174-2021
Lee, Caroine Sunyong

[JCR상위 36.5] Data-driven analysis of bonding strength in laser-structured metal-GFRP hybrid joints via groove morphology
[JCR상위 17.3] c-MET-positive circulating tumor cells and cell-free DNA as independent prognostic factors in hormone receptor-positive/HER2-negative metastatic breast cancer (vol 26, 13, 2024)
SCIE 17.3 AUTOMATION & CONTROL SYSTEMS;ENGINEERING, MANUFACTURING
ONCOLOGY
ahnsh@snu.ac.kr;
ykeeshin@snu.ac.kr; yhparkhmo@skku.edu; ylachoi@skku.edu;
페이지 이동: